Please assess the completion status of the following clinical trial:

Trial Title: Phenazopyridine for Confirmation of Ureteral Patency

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Females only~* Planned surgical procedure where cystoscopy will be used to document ureteral urine flow~* Age \> or = 18 years, no upper age limit~* Able and willing to consent~Exclusion Criteria:~* Planned surgical procedure where cystoscopy will not be used~* Planned surgical procedure where cystoscopy is used for a purpose other than documenting ureteral urine flow~* age \<18 years~* pregnancy~* unable/unwilling to participate~* history of allergy or adverse reaction to phenazopyridine~* hepatic dysfunction~* known phenazopyridine hypersensitivity~* history of urologic surgery~* presence of ureteral stents prior to the planned surgical procedure~* concomitant suprapubic catheter placement

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): No preoperative phenazopyridine
- Phenazopyridine (Type: EXPERIMENTAL): Preoperative phenazopyridine

Based on this trial design, predict the completion outcome and termination type (if applicable).